News of the index components OMX Copenhagen 20

Index

OMXC20

DK0016268840

Market Closed - Nasdaq Copenhagen 08:35:00 17/05/2024 pm IST			5-day change	1st Jan Change
2,729 ^PTS	-0.85%		+2.49%	+19.52%

17/05	Nordic Shares Decreased Friday; Nibe Industrier Series B Fell Furthest	DJ
15/05	Nordic Shares Moved Upward Wednesday; BioArctic Series B Topped Leaders	DJ

News of the index components

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DANSKE BANK : Q1: fading NII momentum shadows good progress on targets achievement DANSKE	03/05
Orsted A/S : Notification of managers' transactions ORSTED	03/05	PU
Notification of managers’ transactions ORSTED	03/05	EQ
Notification of managers’ transactions ORSTED	03/05	AQ
MOLLER-MAERSK : Goldman Sachs reiterates its Neutral rating MAERSK B	03/05	ZD
Danske Bank A/S : Insider transaction disclosure no. 46 DANSKE	03/05	PU
Danske Bank: net income up 9% in Q1 DANSKE	03/05	CF
Danske Bank A/S, transactions by persons discharging managerial responsibilities DANSKE	03/05	GL
Danske Bank Reiterates FY24 Outlook After 'Good' Q1 Performance DANSKE	03/05	MT
ORSTED : Q1 24: Consistent results, no bad news this time ORSTED	03/05
Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024 NSIS B	03/05
Danske Bank CEO: Expects net interest income to top in Q3 DANSKE	03/05	RE
NOVO NORDISK : JP Morgan gives a Buy rating NOVO B	03/05	ZD
Transcript : Danske Bank A/S, Q1 2024 Earnings Call, May 03, 2024 DANSKE	03/05
Q1 update: Novonesis delivers 4% organic sales growth in line with expectations and reports progress on the integration NSIS B	03/05	GL
Trading statement Q1 2024 NSIS B	03/05	GL
Novonesis Provides Sales Guidance for the Year 2024 NSIS B	03/05	CI
Danske Bank A/S : Indicators for assessing systemically important banks 2023 DANSKE	03/05	PU
Danske Bank A/S : Internal Capital Adequacy Assessment - Q1 2024 DANSKE	03/05	PU
Danske Bank A/S : Supervisory Diamond Q1 2024 DANSKE	03/05	PU
Danske Bank reports Q1 net profit in line with expectations DANSKE	03/05	RE
Good start to the year driven by robust customer activity across the business and strong credit quality in uncertain environment. Net profit of DKK 5.6 billion for the first quarter of 2024 DANSKE	03/05	GL
Danske Bank A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 DANSKE	03/05	CI
Danske Bank A/S Provides Earnings Guidance for the Year 2024 DANSKE	03/05	CI
Genmab Posts Q1 Net Profit Surge; Revenue Jumps GMAB	03/05	MT
Genmab A/S : Investor Presentation - May 2024 GMAB	03/05	PU
Novo Nordisk, Eli Lilly's Weight-Loss Drugs Get Price Cuts in UK NOVO B	03/05	MT
Weight-loss drug Wegovy available in Canada starting May 6 for people with obesity NOVO B	02/05	AQ
Genmab Reports Higher Interim Q1 Results; Maintains 2024 Guidance GMAB	02/05	MT
Novo Nordisk CEO: Demand for Wegovy outstrips supply NOVO B	02/05	MT
AP MOLLER-MAERSK : Low-end of the 2024 guidance revised upwards MAERSK B	02/05
NOVO NORDISK : Q1 beat; guidance upgrade but sentiment nonetheless dampened by price reductions NOVO B	02/05
Transcript : Genmab A/S, Q1 2024 Earnings Call, May 02, 2024 GMAB	02/05
Vegfinans Innlandet AS - Successful placement of new NOK bond issue DANSKE	02/05	AQ
GN STORE NORD : Solid profitability boosts investor sentiment GN	02/05
Genmab A/S : Interim Report for the First Quarter of 2024 GMAB	02/05	PU
Genmab A/S : First Quarter 2024 Financial Results Presentation GMAB	02/05	PU
Genmab A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 GMAB	02/05	CI
Genmab Announces Financial Results for the First Quarter of 2024 GMAB	02/05	GL
Moody's Raises Danske Bank’s Ratings; Outlook Changed to Stable DANSKE	02/05	MT